Mental Health Pharma Treatments: Global Markets

Target Date - January 2021| Publisher - BCC Publishing| Code - PHM237A

Mental Health Pharma Treatments: Global Markets

Notify Me

Report Includes
  • An overview of the global markets on mental health pharma treatments
  • Analyses of market trends, with data from 2019, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2027
  • Evaluation of current market trends, market size, market forecast, pipeline analysis of new products, and regulatory scenarios and detailed analysis of drivers, challenges, and opportunities affecting market growth
  • Description of biological factors such as anatomical, chemical and genetic traits, and psychological reasons such as conflict or trauma on the mental health and discussion on effect of COIVD-19 pandemic, social distancing and social isolation on the mental health conditions
  • A look at the markets for treatment of psychiatric disorders such as depression, anxiety and obsessive-compulsive disorder (OCD) and their co relation with COVID-19
  • Details of technological advances and improvement in the development of pharmacological treatments, digital therapeutics (DTx) and cognitive behavioural therapy (CBT)
  • Information on tele mental health software such as ReSet, Pears Somryst and Alkili’s EndeavorRx which offers personalized treatment strategies and behavioural healthcare platform which plays an important role in the management of mental health disorders
  • Snapshot of leading mental health conditions, and products in phase III development for selected psychiatric disorders
  • Analysis of recent product developments including pharmacological and digital therapeutics, late-stage pipeline products and points of differentiation from existing therapies
  • Market share analysis of the key companies of the industry, their strategic profiling, their competitive landscape and their detailed company profiles
Get Notified when New Reports are published
CUSTOM

 

MEMBERSHIP